The company's SimpleSense wearable will ingest glucose data from the Dexcom G7 continuous glucose monitor system.

The company says it partnered with child psychologists to develop an online safety platform for individuals and families to protect children from "technology's negative effects."

The company will use the funds to invest in technology and expand into new market segments.  

The company will use the funds to expand its presence across the U.S. health market and enhance its AI technology and platform. 

Evinova's digital platform will give study sites the ability to monitor patients enrolled in Quantum Leap's clinical trial for interstitial lung disease.